Pharmaceuticals Manufacturers Press Releases from SmartBrief http://www.smartbrief.com/news/BIO/pressReleases.jsp?sb_code=RSS&industry=Pharmaceuticals%20Manufacturers Pharmaceuticals Manufacturers Press Releases from SmartBrief Pittsburgh, Pennsylvania Mother Alleges Her Daughter Almost Died From Side Effects of Bayer's Prescription Drug Yaz Wendy R. Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Dana Kraus, on behalf of her sixteen-year old daughter, Katie Kraus, filed a personal injury lawsuit against Bayer Healthcare Pharmaceutica... Mon, 23 Nov 2009 11:34:16 CST Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients Mon, 23 Nov 2009 08:05:16 CST Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 Mon, 23 Nov 2009 07:34:16 CST Interim Phase 2 Survival Data for PV-10 Shows Markedly Longer Overall and Disease Specific Survival for Subjects Responsive to PV-10 Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed compara... Mon, 23 Nov 2009 06:04:16 CST Amarin Announces Notice of Annual General Meeting Amarin Corporation plc (NASDAQ: AMRN) announced today that it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on December 21, 2009 in Dublin, Ireland. Mon, 23 Nov 2009 05:34:16 CST CDC Software Reports $0.33 in Non-GAAP Earnings Per Share for the Third Quarter of 2009 and Operating Cash Flow of $19.2 Million, up over 200 Percent Year over Year CDC Software Corporation (NASDAQ: CDCS), a global provider of enterprise software applications and services, today announced financial results for the quarter ended September 30, 2009. For the third quarter of 2009, CDC Software reported revenue of (... Mon, 23 Nov 2009 05:34:16 CST Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C PRINCETON, N.J., Nov. 23 /PRNewswire-FirstCall/ -- Pharmasset, Inc. Mon, 23 Nov 2009 05:34:16 CST U.S. Food and Drug Administration Approves ABILIFY (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years) Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFYŽ (aripiprazole) for the treatment of i... Fri, 20 Nov 2009 18:04:16 CST AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured Fri, 20 Nov 2009 09:35:16 CST POZEN Announces Start of Enrollment For PA32540 Phase 3 Program POZEN Inc. (NASDAQ: POZN) announced today the start of enrollment for the phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325 mg of enteric coated aspirin and 40 mg of immediate release omeprazole, under investigation for use in t... Fri, 20 Nov 2009 07:35:16 CST